OSR Health (OSRHW) Common Equity (2021 - 2026)

OSR Health has reported Common Equity for 6 years, with the latest figure at $127.4 million in Q1 2026.

• Quarterly Common Equity fell 3.7% year-over-year to $127.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $127.4 million (down 3.7% YoY) and the FY2025 annual result came in at $127.0 million, down 11.29% from the prior year.
• Common Equity steadied at $127.4 million in Q1 2026 per OSRHW's latest filing, from $127.0 million in the prior quarter.
• Over five years, Common Equity peaked at $153.5 million in Q4 2023 and troughed at -$2.5 million in Q3 2023.
• A 5-year average of $76.3 million and a median of $91.6 million in 2024 frame the typical range for Common Equity.
• The widest YoY moves for Common Equity: up 409310.4% in 2023, down 64665.28% in 2023.
• Over 5 years, Common Equity stood at -$37508.0 in 2022, then surged by 409310.4% to $153.5 million in 2023, then decreased by 6.7% to $143.2 million in 2024, then declined by 11.29% to $127.0 million in 2025, then climbed by 0.28% to $127.4 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $127.4 million, $127.0 million, and $134.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.